Dr Neena Valecha, clinical pharmacologist and malariologist from India is a globally recognized researcher. Dr Valecha has spent over 30 years in malaria research and clinical pharmacology. She worked as Regional Adviser, Malaria at the World Health Organization South East Asia Region (WHO SEARO) for three and a half years and in that position, she provided technical and operational support to national health authorities of countries in the Region for malaria control and Prior to taking up the WHO position, Dr Valecha led the ICMR-National Institute of Malaria Research, the only research institute of India devoted to malaria research, as Director. She provided scientific and technical guidance in the planning, design and implementation, management of research projects to scientists. She also provided strategic guidance to the National Vector Borne Diseases Control Programme of India on various aspects of malaria control policies.
Having started her career as a scientist in premier research organisation in India, that is ICMR, her scientific research focused on malaria treatment, antimalarial drug resistance, quality assurance of diagnostics and clinical trials. Dr Valecha played a key role in introducing artemisinin-based combination therapy (ACT) for treatment for malaria caused by the Plasmodium falciparum in India. She has published over 200 papers in international peer-reviewed journals (H-index:46) and has served on several national and international committees including Malaria Policy advisory committee of WHO. Presently she is member of Malaria Strategic Advisory Panel (MSAP), Bill & Melinda Gates Foundation and Asia Pacific Malaria Elimination Network Vivax Working Group, alternate board member of Roll Back Malaria partnership, Geneva, member of expert scientific advisory group OF Medicines for Malaria Venture (MMV), Geneva.